Skip to main content
HighlightsHighlights Archive

Media Monitoring: 16th April – 23rd April

By April 22, 2022No Comments

UK-Indonesian Partnership announced, life sciences and research namechecked

The UK and Indonesia together intend to:

  •  Strengthen health systems, leveraging research and development to health and life sciences innovations, and better preventing, detecting and responding to infectious diseases through an enhanced Indonesia-UK Health Partnership
  • Build on existing academic collaboration to increase research and development (R&D) programmes in life sciences and technology
  • Build new and deepen existing science and technology R&D partnerships, creating deeper links between our research and innovation communities
  • Support and work collaboratively to enable vaccines, therapeutics and diagnostics to be rapidly developed, and deployed
    – Promote increased networks and connection between the UK and Indonesia’s sectors for digital health and medical technology
    – Enhance cooperation in pathogen genomic sequencing, through the development of regional and bilateral networks for surveillance, training and capacity building
    – Redouble joint efforts to tackle anti-microbial resistance (AMR) through the bilateral partnership and in multilateral fora such as the G20

    Certain bacteria in urine could point to aggressive prostate cancer

  • Experts hope that this new discovery is a crucial marker of aggressive prostate cancer, which could lead to earlier diagnoses
  •  However, more time is needed to fully establish whether the bacteria is a definitive marker of the disease
  •  The University of East Anglia team who led the research are testing whether treating the infection with antibiotics can prevent severe tumours from developing
  •  This research could be vital as current tests cannot accurately predict whether cancers will be harmful or not

    New automated technology can pinpoint the best antibiotics for blood infections

  • This development, led by scientists in China, could be a very useful step in the growing battle against AMR
  • The CAST-R device can isolate specific molecules which can be used to decide which antibiotics are the best to use against different infections
  • Current tests of this nature, using different technology, can take up to two days for a result and often have low accuracy
  • The CAST-R tests gave highly accurate results within 3 hours – a marked improvement on current methods

Protein test found to discover useful biomarker for dementia

  •  A test of protein in the blood provides increasingly compelling evidence of a helpful biomarker of frontotemporal dementia – brain disorders which have few treatment pathways
  • High plasma neurofilament light (NfL) levels were seen to be linked to frontotemporal dementia, even in those with mutations but without the onset of symptoms
  • Elevated levels also signaled the increased severity of the disease

Gene mutation found to indicate aggressive 

  • Scientists have discovered that the mutation of the ARID2 gene is key in marking whether a melanoma will become dangerously metastatic
  •  This discovery suggests that patients with this gene mutation may need to be treated differently to have the chances of a more successful outcome
  •  Melanoma, the deadliest form of skin cancer, has a high survival rate if caught early but can turn incredibly dangerous and aggressive if it spreads